Generics

Strides Pharma receives FDA nod for generic Renvela
Sevelamer Carbonate for Oral Suspension is a medication used to manage elevated levels of phosphate in the blood of patients with chronic kidney disease.
Lupin partners with Mark Cuban Cost Plus Drug Company, COPD Foundation to expand medication access
Lupin’s Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, is the only generic product available that is therapeutically equivalent to Boehringer Ingelheim’s Spiriva HandiHaler.

Amneal obtains FDA OK for calcium gluconate injection

Calcium gluconate in sodium chloride injection is a small volume parenteral bag indicated for the treatment of acute symptomatic hypocalcemia in pediatric and adult patients.
Sandoz inks deal with Samsung Bioepis to commercialize Stelara biosimilar

Ustekinumab is a fully human monoclonal antibody to interleukin (IL)-12/23, approved for treatment of plaque psoriasis, psoriatic arthritis, Crohn´s disease and ulcerative colitis.
DifGen Pharmaceuticals launches generic Suboxone

DifGen Pharmaceuticals also has successfully completed an FDA audit of its manufacturing site in Florida, Aveva Drug Delivery systems.
AAM report: Generic, biosimilar drugs generate $408B in savings

The U.S. healthcare system, including patients, employers and taxpayers, saved $408 billion in 2022 by using FDA-approved generic and biosimilar drugs, per the AAM's report.
Amneal receives first product approval in China

Sevelamer carbonate was approved and is expected to launch shortly.
Amneal obtains FDA OK for generic Vyvanse

Lisdexamfetamine dimesylate is indicated for the treatment of ADHD in patients 6 years and above and for adults with moderate to severe Binge Eating Disorder.
Alkermes reaches settlement with Teva on Vivitrol patent litigation

Alkermes has granted Teva a license to market generic Vivitrol beginning in January 2027.
Alembic intros Erythromycin

Erythromycin tablets are indicated to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.

Strides Pharma receives FDA nod for generic Renvela

Lupin partners with Mark Cuban Cost Plus Drug Company, COPD Foundation to expand medication access

Amneal obtains FDA OK for calcium gluconate injection

Sandoz inks deal with Samsung Bioepis to commercialize Stelara biosimilar

DifGen Pharmaceuticals launches generic Suboxone

AAM report: Generic, biosimilar drugs generate $408B in savings

Amneal receives first product approval in China

Amneal obtains FDA OK for generic Vyvanse

Alkermes reaches settlement with Teva on Vivitrol patent litigation

Alembic intros Erythromycin